We performed analyses of the phenotypic and genotypic relationships focusing 25 on biosyntheses of amino acids, purine/pyrimidines, and co-factors in three 26 long time, the biosynthetic routes established were believed to be common among all 33 microorganisms. However, we now realize that some microorganisms possess 34 alternative biosynthetic pathways since genome data base has enabled us to examine the 35 presence or absence of orthologs of the genes responsible for known biosynthetic 36 pathways. These surveys were one of the triggers to find the 2-C-methyl-D-erythritol 37 4-phosphate pathway (6) for isopentenyl diphosphate biosynthesis and the futalosine 38 pathway (4) for menaquinone biosynthesis. As exemplified by the discovery of these 39 pathways, microorganisms are still expected to have additional alternative biosynthetic 40 pathways for the primary metabolites. 41
1.4 M; http://www.genome.jp/kegg/catalog/org_list.html), we expected the presence of 54 an alternative primary metabolic pathway in Lactobacillus strains. In this paper, we 55 examined the phenotypic and genotypic relationships in Lactobacillus fermentum IFO 56 3956 (genome size, 2.1 M) (10), Lactobacillus reuteri JCM 1112 (2.0 M) (10), and 57
Lactobacillus brevis ATCC 367 (2.3 M) (9), all of which showed relatively good 58 growth with the following synthetic media: LSP medium (patent JP2000-279166; 20 59 g/L glucose, 3.1 g/L KH 2 PO 4 , 1.5 g/L K 2 HPO 4 , 2 g/L diammonium hydrogen citrate, 10 60 g/L potassium acetate, 1 g/L calcium lactate, 0.02 g/L NaCl, 1 g/L tween 80, 0.5 g/L 61
As for the biosynthesis of amino acid, purine/pyrimidines, and vitamin (thiamine, 63 nicotinate, pantothenate, riboflavin, and vitamin B6) biosynthetic pathways, the 64 phenotypes of the three strains were essentially in agreement with the genotype 65 (supporting Table 1 showed the expected enzyme activity. We constructed a ΔfolP E. coli mutant by 80 homologous recombination with the Lambda Red System (Supporting Table 4 and 81
Supporting Fig. 1 ). The constructed ΔfolP E. coli mutant required folic acid for its 82 growth (Supporting Fig. 2 ) and was used in complementation experiments. The ΔfolP E. 83 coli mutant transformed with a plasmid carrying a folP gene cloned from E. coli was 84 able to grow reasonably in the absence of folic acid. Moreover, the ΔfolP E. coli mutant 85 harboring a plasmid carrying LAF_1336 was also able to grow without folic acid 86 (Supporting Fig. 2 ), demonstrating that LAF_1336 complemented the folP defect. 87
We examined LAF_1336 using PABA as the substrate through two strategies. First, 88
we constructed a ΔfolP/ΔpabABC E. coli mutant for in vivo analysis. The ΔfolP E. coli 89 mutant was used for the starting strain and pabA, pabB, and pabC were successively 90 disrupted by homologous recombination. The growth of the constructed mutant, in 91 which PABA was not supplied from chorismate, was completely dependent on the 92 presence of folic acid. When pUC118-FolP, carrying the E.coli folP gene, was 93 introduced into the ΔfolP/ΔpabABC E. coli mutant, the transformant was able to grow in 94 a medium containing PABA as expected ( 
